These are Insider's biggest healthcare stories for April 26.
Insider discussed the risks and benefits of COVID-19 vaccines from AstraZeneca and Johnson & Johnson.
These are Insider's biggest healthcare stories for April 21.
These are Insider's biggest healthcare stories for the week ending April 16.
These are Insider's biggest healthcare stories for April 15.
These are Insider's biggest healthcare stories for April 14.
The US will stop distributing the Johnson & Johnson vaccine temporarily while federal agencies investigate a potential link to blood clots.
Pfizer’s chief executive sees “no issues” in delivering on its COVID-19 vaccine commitments. The company will be able to deliver `at least’ 2 billion doses globally, CEO Albert Bourla said. Visit Business Insider’s homepage for more stories. Pfizer’s chief executive officer is confident that the company can deliver 2 billion […]
Doctors should stop reserving doses needed for second shots, Andy Slavitt, a Biden official said. Slavitt promised states will have “a continual 3-week window in the vaccines that will be shipped.” Providers have cancelled appointments for first doses while they hold back the reserved vaccines. Visit Business Insider’s homepage for […]
Johnson & Johnson fell as much as 3% on Tuesday after it temporarily paused its COVID-19 vaccine trial due to an “unexpected illness” in a trial participant. “Adverse events â€” illnesses, accidents, etc. â€” even those that are serious, are an expected part of any clinical study, especially large studies,” […]
President Donald Trump on Tuesday announced that the US government reached a deal with Moderna for 100 million doses of its coronavirus vaccine candidate. Shares of Moderna spiked as much as 11% in premarket trading Wednesday. The company separately announced the deal is worth $US1.53 billion and gives the government […]
Drug companies are working on developing a coronavirus vaccine at record speed. But a safe, FDA-approved solution may still be several months away. US health officials have said it will take at least 12 months to know if any vaccine works. And the question of who will pay for vaccine […]
On Monday, an Oklahoma judge ordered Johnson & Johnson to pay $US572 million for fuelling the opioid crisis in that state. The suit was one of thousands filed against drugmakers across the country, and the fine was much lower than experts estimated. The punishment will no doubt feel like a […]
The pharmaceutical giant Johnson & Johnson is buying Auris Health, a surgical-robotics company, for $US3.4 billion. Auris makes a controller-operated robotic camera that helps doctors get visuals from within the body, including the lungs. Auris had raised more than $US700 million from investors, and its last valuation as a private […]